How to Buy Structure Therapeutics Stock
Structure Therapeutics Inc
Structure Therapeutics Inc. , a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs.
Structure Therapeutics stock last closed at $50.46, down 2.76% from the previous day, and has increased 123.57% in one year. It has overperformed other stocks in the Biotechnology industry by 1.68 percentage points. Structure Therapeutics stock is currently +281.69% from its 52-week low of $13.22, and -46.83% from its 52-week high of $94.90.
As of Mar 19, 2026, there are 212.53M shares of GPCR outstanding. The market value of GPCR is $3.57B. In the past 24 hours, 896,000 GPCR shares were traded.
How to Buy Structure Therapeutics Stock
Not sure how to invest in Structure Therapeutics stock? Here's how.
- Choose where to buy Structure Therapeutics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you choose where to buy Structure Therapeutics stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Fund your investment account: Choose your payment method and add your info.
- Analyze Structure Therapeutics stock: The Structure Therapeutics ticker symbol is GPCR. Is Structure Therapeutics stock a good investment? Should you buy shares of GPCR? How do GPCR's underlying business fundamentals look? Do top analysts think Structure Therapeutics is a good buy? Why has GPCR's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if GPCR is a good stock to buy).
- Place your GPCR buy order: Decide if you will purchase GPCR shares at the current market price or use a limit order to purchase GPCR shares at a specific price.
- Get key alerts regarding your GPCR position: Create a watchlist to key updates about your position in Structure Therapeutics shares.
Step 1: Choose where to buy Structure Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy GPCR shares.
Our recommended brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world financial markets: From Technology to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal details so you are able to invest in GPCR stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create a new trading account.
- Send your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've created your account on the best stock market app for beginners, you need to deposit funds:
Check out the tutorial below for more details transferring funds into your brokerage account.
Step 4: Analyze Structure Therapeutics stock
After you have chosen the best place to buy Structure Therapeutics stock, it's important to research their stock before you invest, so you truly understand the risk as well as the upside.
Structure Therapeutics stock data
Structure Therapeutics Overview
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on GPCR's stock page.
Is GPCR stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge GPCR's intrinsic value.
Using relative valuations ratios:
- GPCR could be undervalued based on its P/B ratio of 2.36x, relative to Biotechnology industry P/B ratio of 4.68x
You can do additional valuation research on GPCR's stock here.
A look at GPCR Cashflows and Balance Sheet
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the GPCR balance sheet.
- Total GPCR debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the GPCR balance sheet.
- GPCR has $1.45B in cash and short term investments. This is sufficient to cover its annual cash burn of $225.81M.
- GPCR has cash burn of 225813000. It has enough cash and short-term investments to cover this for at least one year.
- GPCR has a low debt to equity ratio of 0.05.
Is it a good time to buy GPCR stock, according to Wall Street analysts?
Out of 9 Wall Street analysts who track GPCR, the consensus analyst rating on Structure Therapeutics is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
Most Recent GPCR Analyst Ratings
Chris Howerton, a top 14% analyst from Jefferies maintains GPCR with a strong buy rating and raises their GPCR price target from $79.00 to $125.00, on Dec 11, 2025.
Jefferies's Chris Howerton raised their price target on Structure Therapeutics (NASDAQ: GPCR) by 58.2% from $79 to $125 on 2025/12/11. The analyst maintained their Strong Buy rating on the stock.
Howerton described Structure Therapeutics' recent positive Phase 2b data for aleniglipron as a "solid win."
Citing the company's extensive de-risked clinical data and advanced research stage, the analyst said they consider Structure Therapeutics as having the "best-in-class small molecule" oral GLP1.
Samantha Semenkow, a top 27% analyst from Citigroup maintains GPCR with a strong buy rating and raises their GPCR price target from $60.00 to $100.00, on Dec 9, 2025.
Annabel Samimy, a top 7% analyst from Stifel Nicolaus maintains GPCR with a strong buy rating and raises their GPCR price target from $50.00 to $90.00, on Dec 9, 2025.
Kaveri Pohlman, a top 24% analyst from Clear Street maintains GPCR with a strong buy rating and raises their GPCR price target from $61.00 to $99.00, on Dec 9, 2025.
You can dig deeper into what analysts are saying on the Structure Therapeutics stock forecast page.
GPCR Technical Indicators
Are GPCR insiders buying or selling the stock?
In the past 12 months, executives and large shareholders at GPCR have sold more shares than they have bought.
Crespo Blas Coll, CHIEF MEDICAL OFFICER of GPCR, was the latest GPCR insider to sell. They sold $248,227.74 worth of GPCR stock on Mar 3, 2026.
Research more about who owns GPCR stock here.
Can I get consistent income from GPCR stock?
No, Structure Therapeutics doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your GPCR buy order
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a given price, place a limit order.
Press the Open Trade button and your broker will place your order.
If you require additional help with buying stocks on eToro, click the helpful video below:
Step 6: Get key alerts regarding your GPCR position
Now that you own some shares in GPCR, you'll want to stay up-to-date on your investment.
Add GPCR to a watchlist to see the latest developments about your GPCR stock.
GPCR Feed
How to Buy Stock in Structure Therapeutics
To reiterate, here are the 6 steps to buy stock in Structure Therapeutics:
- Choose where to buy Structure Therapeutics stock
- Sign up for your brokerage account
- Fund your investment account
- Analyze Structure Therapeutics stock
- Place your GPCR buy order
- Get key alerts regarding your GPCR position
If you require a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep track of your new investment in Structure Therapeutics, get started below.
Other Articles You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.